Mach7 Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Mach7 Technologies wird ein jährliches Gewinn- und Umsatzwachstum von 69.7% bzw. 18.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 69.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.9% betragen.

Wichtige Informationen

69.7%

Wachstumsrate der Gewinne

69.1%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	24.6%
Wachstumsrate der Einnahmen	18.7%
Zukünftige Eigenkapitalrendite	7.9%
Analystenabdeckung	Low
Zuletzt aktualisiert	26 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Jan 29

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Apr 28

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Oct 24

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Jun 23

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

May 19

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Nov 10

Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Jul 27

Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

Feb 19

The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted

Jan 27

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?

Dec 06

Gewinn- und Umsatzwachstumsprognosen

ASX:M7T - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2026	47	3	8	11	5
6/30/2025	39	-2	8	8	5
6/30/2024	30	-7	5	3	5
12/31/2023	27	-6	2	2	N/A
9/30/2023	29	-3	0	0	N/A
6/30/2023	30	-1	-3	-3	N/A
3/31/2023	29	-2	-2	-1	N/A
12/31/2022	28	-4	0	0	N/A
9/30/2022	27	-4	3	3	N/A
6/30/2022	26	-4	6	6	N/A
3/31/2022	26	-3	5	6	N/A
12/31/2021	26	-3	5	5	N/A
9/30/2021	23	-6	3	3	N/A
6/30/2021	19	-9	1	1	N/A
3/31/2021	18	-9	1	1	N/A
12/31/2020	17	-8	0	0	N/A
9/30/2020	18	-4	2	3	N/A
6/30/2020	19	0	5	5	N/A
3/31/2020	17	-1	3	3	N/A
12/31/2019	15	-2	1	1	N/A
9/30/2019	12	-5	-1	-1	N/A
6/30/2019	9	-7	-3	-3	N/A
3/31/2019	9	-7	-4	-4	N/A
12/31/2018	8	-6	-4	-4	N/A
9/30/2018	8	-5	-3	-3	N/A
6/30/2018	9	-5	-2	-2	N/A
3/31/2018	9	-11	-2	-2	N/A
12/31/2017	9	-17	-3	-3	N/A
9/30/2017	10	-17	N/A	-4	N/A
6/30/2017	10	-18	N/A	-5	N/A
3/31/2017	8	-16	N/A	-5	N/A
12/31/2016	6	-15	N/A	-4	N/A
9/30/2016	4	-14	N/A	-4	N/A
6/30/2016	2	-13	N/A	-3	N/A
12/31/2015	8	-3	N/A	N/A	N/A
6/30/2015	0	-7	N/A	-2	N/A
12/31/2014	5	-3	N/A	N/A	N/A
12/31/2013	3	-4	N/A	N/A	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: M7T wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.3%).

Ertrag vs. Markt: M7T wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: M7T wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: M7TDie Einnahmen des Unternehmens (18.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.4% pro Jahr).

Hohe Wachstumseinnahmen: M7TDie Einnahmen des Unternehmens (18.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: M7TDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7.9%).

Mach7 Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 120%

Forecast breakeven date pushed back to 2026

Price target decreased by 7.6% to AU$1.23

Consensus EPS estimates upgraded to AU$0.0045 loss, revenue downgraded

Price target decreased by 9.7% to AU$1.33

Forecast breakeven date pushed back to 2025

Recent updates

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Mach7 Technologies Limited to Report Q3, 2024 Results on Apr 24, 2024

Mach7 Technologies Limited to Report First Half, 2024 Results on Feb 29, 2024

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Consensus EPS estimates fall by 120%

Forecast breakeven date pushed back to 2026

Mach7 Technologies Limited to Report Q2, 2024 Results on Jan 31, 2024

Price target decreased by 7.6% to AU$1.23

Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

Insufficient new directors

Mach7 Technologies Limited Appoints Rebecca Thompson as Director

Independent Non-Executive Director exercised options to buy AU$158k worth of stock.

Consensus EPS estimates upgraded to AU$0.0045 loss, revenue downgraded

Mach7 Technologies Limited to Report Q1, 2024 Results on Oct 31, 2023

New minor risk - Market cap size

Price target decreased by 9.7% to AU$1.33

Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

CEO, MD & Director exercised options and sold AU$65k worth of stock

Mach7 Technologies Limited Announces Board Changes, Effective 16 November 2023

Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)

Forecast breakeven date pushed back to 2025

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Financial data availability

Mach7 Technologies Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

Mach7 Technologies Limited, Annual General Meeting, Nov 16, 2023

Mach7 Technologies Limited to Report Q4, 2023 Results on Jul 31, 2023

Price target increased by 13% to AU$1.49

Independent Non-Executive Chairman exercised options to buy AU$140k worth of stock.

Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

Now 21% undervalued after recent price drop

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Now 20% undervalued after recent price drop

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2022)

Consensus EPS estimates upgraded to AU$0.009 loss, revenue downgraded

Mach7 Technologies Limited Announces Change of Company Secretary

Mach7 Technologies Limited Provides Revenue Guidance for the Year 2023

Mach7 Technologies Limited Announces Executive Changes, Effective January 1, 2023

Consensus forecasts updated

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Mach7 Technologies Limited, Annual General Meeting, Nov 17, 2022

Consensus forecasts updated

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$1.27

Mach7 Technologies Limited to Report Q4, 2022 Results on Aug 29, 2022

Mach7 Technologies Limited to Report Q4, 2022 Results on Jul 21, 2022

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

Price target decreased to AU$1.38

Price target decreased to AU$1.38

Consensus forecasts updated

Consensus forecasts updated

First half 2022 earnings: EPS and revenues miss analyst expectations

Mach7 Technologies Limited to Report First Half, 2022 Results on Feb 28, 2022

Mach7 Technologies Limited to Report Q2, 2022 Results on Jan 31, 2022

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Company Secretary Jennifer Pilcher has left the company

Mach7 Technologies Limited Provides Earning Guidance for the Calendar Year 2021

Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Price target decreased to AU$1.56

First half 2021 earnings released: AU$0.031 loss per share (vs AU$0.004 profit in 1H 2020)

Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

Price target raised to AU$1.68

Analysts update estimates

Mach7 Technologies Limited to Report First Half, 2021 Results on Feb 18, 2021

New 90-day high: AU$1.57

Mach7 Technologies Limited Provides Update on Its Project with the Hospital Authority of Hong Kong

The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted